Royal Brompton & Harefield NHS Foundation Trust

🇬🇧United Kingdom

Country: 🇬🇧United Kingdom

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.rbht.nhs.uk

Clinical Trials

Electronic Hand Hygiene Monitoring and ICU Infection Rates

Completed

Conditions: Cross Infection

Interventions: Other: Weekly poster of unit performance
Other: Daily email of personal feedback
Other: Active reminder from badge

First Posted Date: 2015-07-30

Last Posted Date: 2015-07-30

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 1065

Registration Number: NCT02511925

Locations: 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom

Reliability of the 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis

Completed

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Other: 4MGS

First Posted Date: 2015-05-15

Last Posted Date: 2015-10-27

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 46

Registration Number: NCT02445157

Locations: 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom

Intrinsic PEEP and Laryngeal Aperture in COPD

Conditions: Chronic Obstructive Pulmonary Disease

Interventions: Procedure: Oesophageal balloon to measure intra-thoracic pressure
Procedure: Fibre-optic laryngoscopy
Other: standard lung function tests
Procedure: face mask CPAP
Procedure: variation of mouth pressure with CPAP
Other: facemask pneumotachograph

First Posted Date: 2015-05-07

Last Posted Date: 2017-06-07

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 30

Registration Number: NCT02437630

Locations: 🇬🇧
michael apps MD, London, United Kingdom

The Predictive Ability of 4MGS in IPF

Completed

Conditions: Idiopathic Pulmonary Fibrosis

Interventions: Other: 4MGS

First Posted Date: 2015-05-06

Last Posted Date: 2017-11-09

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 132

Registration Number: NCT02436278

Locations: 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Harefield, Middlesex, United Kingdom

A Pilot Study of Transcoronary Myocardial Cooling

Not Applicable

Completed

Conditions: Acute Myocardial Infarction

Interventions: Other: Cohort A - Room temperature coronary perfusate
Other: Cohort B - Cooled coronary perfusate

First Posted Date: 2014-12-09

Last Posted Date: 2015-07-28

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 10

Registration Number: NCT02312336

Locations: 🇬🇧
Royal Brompton and Harefield NHS Foundation Trust, Uxbridge, Middlesex, United Kingdom

Ambulatory Oxygen in Fibrotic Lung Disease (FLD) (AmbOx)

Phase 4

Completed

Conditions: Lung; Disease, Fibroid (Chronic)

Interventions: Drug: Ambulatory Oxygen

First Posted Date: 2014-11-07

Last Posted Date: 2018-06-26

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 70

Registration Number: NCT02286063

Locations: 🇬🇧
Royal Brompton Hospital, London, United Kingdom

A Pilot Study Into Health Pre and Post Treatment With Intravenous Aminophylline and Hydrocortisone in Severe Asthmatics

Terminated

Conditions: Asthma

First Posted Date: 2014-10-21

Last Posted Date: 2015-10-28

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 5

Registration Number: NCT02270827

Locations: 🇬🇧
Royal Brompton Hospital, London, United Kingdom

Oral Verses Patch Trial In Menopausal Women - Individualisation of Oestrogen Therapy

Phase 4

Conditions: Venous Thrombosis
Insulin Resistance

Interventions: Drug: Femoston Conti
Drug: EVOREL® CONTI

First Posted Date: 2014-10-15

Last Posted Date: 2014-10-15

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 60

Registration Number: NCT02264743

Locations: 🇬🇧
Chelsea and Westminster NHS Foundation Trust, London, United Kingdom
🇬🇧
Royal Brompton and Harefield NHS Trust, London, United Kingdom
🇬🇧
Imperial College Healthcare NHS Trust, London, United Kingdom

Post-hospitalisation Nutritional Support and Gait Speed in COPD

Phase 3

Terminated

Conditions: Respiratory Tract Diseases
Bronchitis, Chronic
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Pulmonary Emphysema

Interventions: Dietary Supplement: Food fortification
Dietary Supplement: Oral Nutritional Supplements

First Posted Date: 2014-10-10

Last Posted Date: 2015-11-01

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 22

Registration Number: NCT02261350

Locations: 🇬🇧
The Hillingdon Hospital NHS Foundation Trust, Uxbridge, Middlesex, United Kingdom

Is Gait Speed and Sarcopenia Prognostic in Chronic Respiratory Disease?

Completed

Conditions: Chronic Obstructive Pulmonary Disease and Allied Conditions

First Posted Date: 2014-10-10

Last Posted Date: 2022-11-01

Lead Sponsor: Royal Brompton & Harefield NHS Foundation Trust

Target Recruit Count: 565

Registration Number: NCT02261337

Locations: 🇬🇧
Harefield hospital, Harefield, Middlesex, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy